Deletion of Orai1 alters expression of multiple genes during osteoclast and osteoblast maturation

Cell Calcium

Volumn 52, Issue 6, 2012, Pages 488-500

  Hwang, Sung Yong ^a,b   Foley, Julie ^a   Numaga Tomita, Takuro ^a   Petranka, John G ^a   Bird, Gary S ^a   Putney, James W ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Bone development; Gene regulation; Knock out mouse; Orai1; Store operated channels

Indexed keywords

CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE REMODELING; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN FUNCTION;

MUS;

EID: 84870300351     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2012.10.001     Document Type: Article

References (67)

1. Karsenty G., Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Developmental Cell 2002, 2:389-406.
2. Zaidi M. Skeletal remodeling in health and disease. Nature Medicine 2007, 13:791-801.
3. Novack D.V., Teitelbaum S.L. The osteoclast: friend or foe?. Annual Review of Pathology 2008, 3:457-484.
4. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliott R., Colombero A., Tan H.L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T.M., Hill D., Pattison W., Campbell P., Sander S., Van G., Tarpley J., Derby P., Lee R., Boyle W.J. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309-319.
5. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:3597-3602.
6. Rodan G.A., Martin T.J. Therapeutic approaches to bone diseases. Science 2000, 289:1508-1514.
7. Romas E., Gillespie M.T., Martin T.J. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 2002, 30:340-346.
8. Raisz L.G. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. Journal of Clinical Investigation 2005, 115:3318-3325.
9. Takayanagi H. Osteoimmunology and the effects of the immune system on bone. Nature Reviews: Rheumatology 2009, 5:667-676.
10. Chan G.K., Duque G. Age-related bone loss: old bone, new facts. Gerontology 2002, 48:62-71.
11. Rosen C.J., Bouxsein M.L. Mechanisms of disease: is osteoporosis the obesity of bone?. Nature Clinical Practice: Rheumatology 2006, 2:35-43.
12. Yavropoulou M.P., Yovos J.G. Osteoclastogenesis-current knowledge and future perspectives. Journal of Musculoskeletal and Neuronal Interactions 2008, 8:204-216.
13. Kenner L., Hoebertz A., Beil F.T., Keon N., Karreth F., Eferl R., Scheuch H., Szremska A., Amling M., Schorpp-Kistner M., Angel P., Wagner E.F. Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. Journal of Cell Biology 2004, 164:613-623.
14. Sabatakos G., Sims N.A., Chen J., Aoki K., Kelz M.B., Amling M., Bouali Y., Mukhopadhyay K., Ford K., Nestler E.J., Baron R. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nature Medicine 2000, 6:985-990.
15. Neve A., Corrado A., Cantatore F.P. Osteoblast physiology in normal and pathological conditions. Cell and Tissue Research 2011, 343:289-302.
16. Eferl R., Hoebertz A., Schilling A.F., Rath M., Karreth F., Kenner L., Amling M., Wagner E.F. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO Journal 2004, 23:2789-2799.
17. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 1993, 361:315-325.
18. Carafoli E. Calcium signaling: a tale for all seasons. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:1115-1122.
19. Xia S.L., Ferrier J. Localized calcium signaling in multinucleated osteoclasts. Journal of Cellular Physiology 1996, 167:148-155.
20. Duncan R.L., Akanbi K.A., Farach-Carson M.C. Calcium signals and calcium channels in osteoblastic cells. Seminars in Nephrology 1998, 18:178-190.
21. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., Saiura A., Isobe M., Yokochi T., Inoue J., Wagner E.F., Mak T.W., Kodama T., Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Developmental Cell 2002, 3:889-901.
22. Jorgensen N.R., Geist S.T., Civitelli R., Steinberg T.H. ATP- and gap junction-dependent intercellular calcium signaling in osteoblastic cells. Journal of Cell Biology 1997, 139:497-506.
23. Bergh J.J., Xu Y., Farach-Carson M.C. Osteoprotegerin expression and secretion are regulated by calcium influx through the L-type voltage-sensitive calcium channel. Endocrinology 2004, 145:426-436.
24. Blair H.C., Schlesinger P.H., Huang C.L., Zaidi M. Calcium signalling and calcium transport in bone disease. Sub-Cellular Biochemistry 2007, 45:539-562.
25. Hwang S.Y., Putney J.W. Calcium signaling in osteoclasts. Biochimica et Biophysica Acta 2011, 1813:979-983.
26. Parekh A.B., Putney J.W. Store-operated calcium channels. Physiological Reviews 2005, 85:757-810.
27. Parekh A.B. Functional consequences of activating store-operated CRAC channels. Cell Calcium 2007, 42:111-121.
28. Vig M., Beck A., Billingsley J.M., Lis A., Parvez S., Peinelt C., Koomoa D.L., Soboloff J., Gill D.L., Fleig A., Kinet J.P., Penner R. CRACM1 multimers form the ion-selective pore of the CRAC channel. Current Biology 2006, 16:2073-2079.
29. Prakriya M., Feske S., Gwack Y., Srikanth S., Rao A., Hogan P.G. Orai1 is an essential pore subunit of the CRAC channel. Nature 2006, 443:230-233.
30. Feske S., Gwack Y., Prakriya M., Srikanth S., Puppel S.H., Tanasa B., Hogan P.G., Lewis R.S., Daly M., Rao A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006, 441:179-185.
31. Hwang S.Y., Putney J.W. Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1. FASEB Journal 2012, 26:1484-1492.
32. Wiemann M., Busselberg D., Schirrmacher K., Bingmann D. A calcium release activated calcium influx in primary cultures of rat osteoblast-like cells. Calcified Tissue International 1998, 63:154-159.
33. Labelle D., Jumarie C., Moreau R. Capacitative calcium entry and proliferation of human osteoblast-like MG-63 cells. Cell Proliferation 2007, 40:866-884.
34. Robinson L.J., Mancarella S., Songsawad D., Tourkova I.L., Barnett J.B., Gill D.L., Soboloff J., Blair H.C. Gene disruption of the calcium channel Orai1 results in inhibition of osteoclast and osteoblast differentiation and impairs skeletal development. Laboratory Investigation 2012, 92:1071-1083.
35. Vig M., DeHaven W.I., Bird G.S., Billingsley J.M., Wang H., Rao P.E., Hutchings A.B., Jouvin M.H., Putney J.W., Kinet J.P. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nature Immunology 2008, 9:89-96.
36. Cheng S.L., Yang J.W., Rifas L., Zhang S.F., Avioli L.V. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 1994, 134:277-286.
37. Gregory C.A., Gunn W.G., Peister A., Prockop D.J. An Alizarin Red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Analytical Biochemistry 2004, 329:77-84.
38. Maeda T., Matsunuma A., Kurahashi I., Yanagawa T., Yoshida H., Horiuchi N. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. Journal of Cellular Biochemistry 2004, 92:458-471.
39. Matsubara T., Kida K., Yamaguchi A., Hata K., Ichida F., Meguro H., Aburatani H., Nishimura R., Yoneda T. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. Journal of Biological Chemistry 2008, 283:29119-29125.
40. Cao H., Yu S., Yao Z., Galson D.L., Jiang Y., Zhang X., Fan J., Lu B., Guan Y., Luo M., Lai Y., Zhu Y., Kurihara N., Patrene K., Roodman G.D., Xiao G. Activating transcription factor 4 regulates osteoclast differentiation in mice. Journal of Clinical Investigation 2010, 120:2755-2766.
41. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., Amling M., Karsenty G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes and Development 1999, 13:1025-1036.
42. Wilkins B.J., De Windt L.J., Bueno O.F., Braz J.C., Glascock B.J., Kimball T.F., Molkentin J.D. Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Molecular and Cellular Biology 2002, 22:7603-7613.
43. Salingcarnboriboon R., Tsuji K., Komori T., Nakashima K., Ezura Y., Noda M. Runx2 is a target of mechanical unloading to alter osteoblastic activity and bone formation in vivo. Endocrinology 2006, 147:2296-2305.
44. Yagi M., Miyamoto T., Sawatani Y., Iwamoto K., Hosogane N., Fujita N., Morita K., Ninomiya K., Suzuki T., Miyamoto K., Oike Y., Takeya M., Toyama Y., Suda T. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. Journal of Experimental Medicine 2005, 202:345-351.
45. Lee S.H., Rho J., Jeong D., Sul J.Y., Kim T., Kim N., Kang J.S., Miyamoto T., Suda T., Lee S.K., Pignolo R.J., Koczon-Jaremko B., Lorenzo J., Choi Y. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nature Medicine 2006, 12:1403-1409.
46. Koga T., Matsui Y., Asagiri M., Kodama T., de Crombrugghe B., Nakashima K., Takayanagi H. NFAT and Osterix cooperatively regulate bone formation. Nature Medicine 2005, 11:880-885.
47. Castro-Malaspina H., Gay R.E., Resnick G., Kapoor N., Meyers P., Chiarieri D., McKenzie S., Broxmeyer H.E., Moore M.A. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980, 56:289-301.
48. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. Journal of Cellular Biochemistry 1997, 64:295-312.
49. Wong M.M., Rao L.G., Ly H., Hamilton L., Tong J., Sturtridge W., McBroom R., Aubin J.E., Murray T.M. Long-term effects of physiologic concentrations of dexamethasone on human bone-derived cells. Journal of Bone and Mineral Research 1990, 5:803-813.
50. Kasugai S., Todescan R., Nagata T., Yao K.L., Butler W.T., Sodek J. Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: inductive effects of dexamethasone on the osteoblastic phenotype. Journal of Cellular Physiology 1991, 147:111-120.
51. Fernandez M., Minguell J.J. Hydrocortisone regulates types I and III collagen gene expression and collagen synthesis in human marrow stromal cells. Biological Research 1997, 30:85-90.
52. Zhou Y., Lewis T.L., Robinson L.J., Brundage K.M., Schafer R., Martin K.H., Blair H.C., Soboloff J., Barnett J.B. The role of calcium release activated calcium channels in osteoclast differentiation. Journal of Cellular Physiology 2010, 226:1082-1089.
53. 2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. Journal of Clinical Investigation 2003, 112:1906-1914.
54. 2+ channel TRPV5 is essential for proper osteoclastic bone resorption. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:17507-17512.
55. Masuyama R., Vriens J., Voets T., Karashima Y., Owsianik G., Vennekens R., Lieben L., Torrekens S., Moermans K., Vanden B.A., Bouillon R., Nilius B., Carmeliet G. TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts. Cell Metabolism 2008, 8:257-265.
56. Kajiya H., Okamoto F., Nemoto T., Kimachi K., Toh-Goto K., Nakayana S., Okabe K. RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations. Cell Calcium 2010, 48:260-269.
57. 2+ entry pathway in rat osteoblast-like cells. Journal of Cellular Biochemistry 2002, 86:678-687.
58. Zhao H., Ito Y., Chappel J., Andrews N.W., Teitelbaum S.L., Ross F.P. Synaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretion. Developmental Cell 2008, 14:914-925.
59. Baldi C., Vazquez G., Calvo J.C., Boland R. TRPC3-like protein is involved in the capacitative cation entry induced by 1alpha,25-dihydroxy-vitamin D3 in ROS 17/2.8 osteoblastic cells. Journal of Cellular Biochemistry 2003, 90:197-205.
60. 2+ conducting channels in an osteoblast-like cell line (UMR 106). FEBS Letters 1989, 251:17-21.
61. Jorgensen N.R., Teilmann S.C., Henriksen Z., Civitelli R., Sorensen O.H., Steinberg T.H. Activation of L-type calcium channels is required for gap junction-mediated intercellular calcium signaling in osteoblastic cells. Journal of Biological Chemistry 2003, 278:4082-4086.
62. Gwack Y., Srikanth S., Oh-hora M., Hogan P.G., Lamperti E.D., Yamashita M., Gelinas C., Neems D.S., Sasaki Y., Feske S., Prakriya M., Rajewsky K., Rao A. Hair loss and defective T- and B-cell function in mice lacking ORAI1. Molecular and Cellular Biology 2008, 28:5209-5222.
63. Stiber J., Hawkins A., Zhang Z.S., Wang S., Burch J., Graham V., Ward C.C., Seth M., Finch E., Malouf N., Williams R.S., Eu J.P., Rosenberg P. STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle. Nature Cell Biology 2008, 10:688-697.
64. Li B., Boast S., de los S.K., Schieren I., Quiroz M., Teitelbaum S.L., Tondravi M.M., Goff S.P. Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nature Genetics 2000, 24:304-308.
65. Hoshino A., Iimura T., Ueha S., Hanada S., Maruoka Y., Mayahara M., Suzuki K., Imai T., Ito M., Manome Y., Yasuhara M., Kirino T., Yamaguchi A., Matsushima K., Yamamoto K. Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts. Journal of Biological Chemistry 2010, 285:28826-28837.
66. Levaot N., Simoncic P.D., Dimitriou I.D., Scotter A., La R.J., Ng A.H., Willett T.L., Wang C.J., Janmohamed S., Grynpas M., Reichenberger E., Rottapel R. 3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions. Journal of Clinical Investigation 2011, 121:3244-3257.
67. 2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. Journal of Allergy and Clinical Immunology 2009, 124:1311-1318.